(A) PCA score scatter plots; (B)Heat map visualization of detected metabolites in PD and D phases; Various colors in the figure represent the relative content. by Bingshuo Shi (21485387)

Cost-effectiveness acceptability curve. by Yiping An (20609789)

Subjects:

Markov model. by Yiping An (20609789)

Subjects:

Incremental cost-effectiveness scatter plot. by Yiping An (20609789)

Subjects:

ICER changes with time horizon. by Yiping An (20609789)

Subjects:

a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... by Iva Milinkovic (22331710)

Characteristics of the included studies. by Xin Liu (43569)

Subjects:

Summary of results. by Xin Liu (43569)

Subjects:

Bias risk assessments for each RCT study. by Xin Liu (43569)

Subjects:

The flow chart of studies selecting. by Xin Liu (43569)

Subjects:

Funnel plots for intraoperative blood loss. by Xin Liu (43569)

Subjects:

Bias risk assessments for each RCS study. by Xin Liu (43569)

Subjects:

Patient status overview. by Farayi Kaseke (19560197)

Subjects:

Risk Illustration. by Iftikhar Ali Ch (20783753)

Subjects:

Predictors of SCD. by Iftikhar Ali Ch (20783753)

Subjects:

Clinical outcomes. by Iftikhar Ali Ch (20783753)

Subjects:

Obesity and Depressed Ejection Fraction. by Iftikhar Ali Ch (20783753)

Subjects:

Kaplan Meier curve. by Iftikhar Ali Ch (20783753)

Subjects:

Definitions of variables. by Qi Zhang (28502)

Subjects:

PSM and Heckman regression results. by Qi Zhang (28502)

Subjects: